Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta Adrenergic Antagonist For The Healing of Chronic Diabetic Foot Ulcers

NCT03282981 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT03282981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03282981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta Adrenergic Antagonist For The Healing of Chronic Diabetic Foot Ulcers
Lead sponsor
VA Office of Research and Development
Phase
Phase 3
Overall status
Completed
Start date
July 24, 2018
Completion date
April 30, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic diabetic foot ulcers, diabetic neuropathic ulcers, non healing wound